EPIZYME, INC. Deferred Tax Assets, Net of Valuation Allowance
EPIZYME, INC. had Deferred Tax Assets, Net of Valuation Allowance of $5.30 million as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2022-03-01
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $5.30M.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $4.84M.
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $5.86M.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $218.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2021-12-31 | $5.30M 10-K · filed 2022-03-01 |
| 2020-12-31 | $4.84M 10-K · filed 2022-03-01 |
| 2019-12-31 | $5.86M 10-K · filed 2021-02-23 |
| 2018-12-31 | $218.00K 10-K · filed 2020-02-27 |
| 2017-12-31 | $433.00K 10-K · filed 2019-02-26 |
| 2016-12-31 | $258.00K 10-K · filed 2018-03-13 |
| 2015-12-31 | $254.00K 10-K · filed 2017-03-13 |
| 2014-12-31 | $312.00K 10-K · filed 2016-03-09 |
| 2013-12-31 | $299.00K 10-K · filed 2015-03-12 |
| 2012-12-31 | $81.00K 10-K · filed 2014-02-28 |